[
1. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-46.10.1161/CIRCULATIONAHA.113.00689825047584
]Search in Google Scholar
[
2. Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006; 355(5):488-98.10.1056/NEJMra05528916885552
]Search in Google Scholar
[
3. Meissner MH, Moneta G, Burnand K, Gloviczki P, Lohr JM, Lurie F, et al. The hemodynamics and diagnosis of venous disease. J Vasc Surg. 2007;46(Suppl S):4S-24S.10.1016/j.jvs.2007.09.04318068561
]Search in Google Scholar
[
4. Raffetto JD. Pathophysiology of Chronic Venous Disease and Venous Ulcers. Surg Clin North Am. 2018;98(2):337-47.10.1016/j.suc.2017.11.00229502775
]Search in Google Scholar
[
5. Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology. 2012; 27(Suppl 1):114-8.10.1258/phleb.2012.012s1922312077
]Search in Google Scholar
[
6. Neubauer-Geryk J, Bieniaszewski L. Przewlekla choroba zylna – patofizjologia, obraz kliniczny i leczenie. Choroby Serca i Naczyn. 2009;6(3):135-41.
]Search in Google Scholar
[
7. Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342-52.10.1016/j.jvsv.2019.12.07532113854
]Search in Google Scholar
[
8. Eklof B, Perrin M, Delis KT, Rutherford RB, Gloviczki P. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg. 2009;49(2):498-501.10.1016/j.jvs.2008.09.01419216970
]Search in Google Scholar
[
9. Vuylsteke ME, Colman R, Thomis S, Guillaume G, Van Quickenborne D, Staelens I. an epidemiological survey of venous disease among general practitioner attendees in different geographical regions on the globe: The final results of the Vein Consult Program. Angiology. 2018;69(9):779-85.10.1177/000331971875983429482348
]Search in Google Scholar
[
10. Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F. VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105-15.
]Search in Google Scholar
[
11. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15(3):175-84.10.1016/j.annepidem.2004.05.01515723761
]Search in Google Scholar
[
12. Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: Multicentre cross-sectional study in 40.095 patients. Phlebology. 2003;18:110-22.10.1258/026835503322381315
]Search in Google Scholar
[
13. Ziaja D, Sznapka M, Grzela J, Kostecki J, Biolik G, Pawlicki K, et al. Regional variations of symptoms of the chronic venous disease among primary health care patients in Poland. Acta Angiologica. 2015;21(2):31-9.10.5603/AA.2015.0007
]Search in Google Scholar
[
14. Vuylsteke ME, Thomis S, Guillaume G, Modliszewski ML, Weides N, Staelens I. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur J Vasc Endovasc Surg. 2015;49(4):432-9.10.1016/j.ejvs.2014.12.03125701071
]Search in Google Scholar
[
15. Curylo M, Cienkosz K, Mikos M, Czerw A. Epidemiology and diagnostics of venous disease in Poland. J Educ Health Sport. 2017; 7(9):49-57.
]Search in Google Scholar
[
16. Nicolaides AN. Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). Circulation. 2000; 102(20):E126-63.10.1161/01.CIR.102.20.e126
]Search in Google Scholar
[
17. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et al. Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S-48S.10.1016/j.jvs.2011.01.079
]Search in Google Scholar
[
18. Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med. 2019;34(2):269-83.10.3904/kjim.2018.230640610330360023
]Search in Google Scholar
[
19. Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, et al. Editor’s choice – management of Chronic Venous Disease: Clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6): 678-737.10.1016/j.ejvs.2015.02.00725920631
]Search in Google Scholar
[
20. Smith RK, Golledge J. A systematic review of circulating markers in primary chronic venous insufficiency. Phlebology. 2014;29(9):570-9.10.1177/026835551349437523928282
]Search in Google Scholar
[
21. Wojciechowska A, Braniewska A, Kozar-Kaminska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017; 26(5):865-74.10.17219/acem/6291529068585
]Search in Google Scholar
[
22. Stepien E, Costa MC, Kurc S, Drozdz A, Cortez-Dias N, Enguita FJ. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases. Acta Pharmacol Sin. 2018;39(7):1085-99.10.1038/aps.2018.35628936929877319
]Search in Google Scholar
[
23. Zhou SS, Jin JP, Wang JQ, Zhang ZG, Freedman JH, Zheng Y, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39(7): 1073-84.10.1038/aps.2018.30628936329877320
]Search in Google Scholar
[
24. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835-40.10.1038/nature09267299049920703300
]Search in Google Scholar
[
25. Kim D, Sung YM, Park J, Kim S, Kim J, Park J, et al. General rules for functional microRNA targeting. Nat Genet. 2016;48:1517-26.10.1038/ng.369427776116
]Search in Google Scholar
[
26. Oliveto S, Mancino M, Manfrini N, Biffo S. Role of microRNAs in translation regulation and cancer. World J Biol Chem. 2017;8(1): 45-56.10.4331/wjbc.v8.i1.45532971428289518
]Search in Google Scholar
[
27. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat Genet. 2011;43:854-9.10.1038/ng.905316376421857679
]Search in Google Scholar
[
28. Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203-22.10.1038/nrd.2016.24628209991
]Search in Google Scholar
[
29. Bogucka-Kocka A, Zalewski DP, Ruszel KP, Stepniewski A, Galkowski D, Bogucki J, et al. Dysregulation of MicroRNA regulatory network in lower extremities arterial disease. Front Genet. 2019;10:1200.10.3389/fgene.2019.01200689235931827490
]Search in Google Scholar
[
30. Zhou SS, Jin JP, Wang JQ, Zhang ZG, Freedman JH, Zheng Y, et al. miRNAS in cardiovascular diseases: Potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39: 1073-84.10.1038/aps.2018.30628936329877320
]Search in Google Scholar
[
31. Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis. Circ Res. 2016;118:703-20.10.1161/CIRCRESAHA.115.306300476206926892968
]Search in Google Scholar
[
32. Schulte C, Karakas M, Zeller T. MicroRNAs in cardiovascular disease – Clinical application. Clin Chem Lab Med. 2017;55:687-704.10.1515/cclm-2016-057627914211
]Search in Google Scholar
[
33. Zalewski DP, Ruszel KP, Stepniewski A, Galkowski D, Bogucki J, Komsta L, et al. Dysregulation of microRNA modulatory network in abdominal aortic aneurysm. J Clin Med. 2020;9(6):1974.10.3390/jcm9061974735541532599769
]Search in Google Scholar
[
34. Zhang C. MicroRNAs in vascular biology and vascular disease. J Cardiovasc Transl Res. 2010;3(3):235-40.10.1007/s12265-010-9164-z362644120560045
]Search in Google Scholar
[
35. Fernández-Hernando C, Suárez Y. MicroRNAs in endothelial cell homeostasis and vascular disease. Curr Opin Hematol. 2018;25: 227-36.10.1097/MOH.0000000000000424617570429547400
]Search in Google Scholar
[
36. Qin S, Zhang C. MicroRNAs in vascular disease. J Cardiovasc Pharmacol. 2011;57:8-12.10.1097/FJC.0b013e318203759b451718421052012
]Search in Google Scholar
[
37. Cui C, Liu G, Huang Y, Lu X, Lu M, Huang X, et al. MicroRNA profiling in great saphenous vein tissues of patients with chronic venous insufficiency. Tohoku J Exp Med. 2012;228(4):341-50.10.1620/tjem.228.34123132275
]Search in Google Scholar
[
38. Huang X, Liu Z, Shen L, Jin Y, Xu G, Zhang Z, et al. Augmentation of miR-202 in varicose veins modulates phenotypic transition of vascular smooth muscle cells by targeting proliferator-activated receptor-γ coactivator-1α. J Cell Biochem. 2019;120(6):10031-42.10.1002/jcb.2828730556158
]Search in Google Scholar
[
39. Anwar MA, Adesina-Georgiadis KN, Spagou K, Vorkas PA, Li JV, Shalhoub J, et al. A comprehensive characterisation of the metabolic profile of varicose veins; implications in elaborating plausible cellular pathways for disease pathogenesis. Sci Rep. 2017;7(1):2989.10.1038/s41598-017-02529-y546275428592827
]Search in Google Scholar
[
40. Zalewski DP, Ruszel KP, Stepniewski A, Galkowski D, Bogucki J, Komsta L, et al. Dysregulations of MicroRNA and gene expression in Chronic Venous Disease. J Clin Med. 2020;9(5):1251.10.3390/jcm9051251728787832344947
]Search in Google Scholar
[
41. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins. J Vasc Surg. 2008;48(2):447-56.10.1016/j.jvs.2008.03.004257503918502086
]Search in Google Scholar
[
42. Biranvand AS, Khosravi M, Esfandiari G, Poursaleh A, Hosseini-Fard SR, Amirfarhangi A, et al. Associations between miR-661, miR-1202, lncRNA-HOTAIR, lncRNA-GAS5 and MMP9 in differentiated M2-macrophages of patients with varicose veins. Int Angiol. 2018;37(6):451-6.10.23736/S0392-9590.18.04022-130558403
]Search in Google Scholar
[
43. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384-8.10.1038/nature1199323446346
]Search in Google Scholar
[
44. Zhang W, Li L, Si Y, Shi Z, Zhu T, Zhuang S, et al. Identification of aberrant circular RNA expression and its potential clinical value in primary great saphenous vein varicosities. Biochem Biophys Res Commun. 2018;499(2):328-37.10.1016/j.bbrc.2018.03.15629577902
]Search in Google Scholar
[
45. Pastar I, Khan AA, Stojadinovic O, Lebrun EA, Medina MC, Brem H, et al. Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem. 2012;287(35):29324-35.10.1074/jbc.M112.382135343619722773832
]Search in Google Scholar
[
46. Wu J, Li X, Li D, Ren X, Li Y, Herter EK, et al. MicroRNA-34 family enhances wound inflammation by targeting LGR4. J Invest Dermatol. 2020;140(2):465-76.e11.10.1016/j.jid.2019.07.694
]Search in Google Scholar
[
47. Jin Y, Xu G, Huang J, Zhou D, Huang X, Shen L. Analysis of the association between an insertion/deletion polymorphism within the 3’ untranslated region of COL1A2 and chronic venous insufficiency. Ann Vasc Surg. 2013;27(7):959-63.10.1016/j.avsg.2013.04.00123849651
]Search in Google Scholar
[
48. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation. 2002;106(4):479-83.10.1161/01.CIR.0000022846.22923.46
]Search in Google Scholar